Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glioma | 16 | 2024 | 3418 | 1.710 |
Why?
|
Brain Neoplasms | 16 | 2024 | 8981 | 1.190 |
Why?
|
Proto-Oncogene Proteins B-raf | 7 | 2024 | 2053 | 0.720 |
Why?
|
Ependymoma | 2 | 2017 | 320 | 0.560 |
Why?
|
Nanotechnology | 2 | 2019 | 707 | 0.530 |
Why?
|
Gene Rearrangement | 1 | 2020 | 1122 | 0.480 |
Why?
|
MAP Kinase Signaling System | 3 | 2022 | 1477 | 0.470 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2020 | 1594 | 0.440 |
Why?
|
Histones | 3 | 2020 | 2577 | 0.430 |
Why?
|
Thalamus | 2 | 2016 | 1040 | 0.430 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 3 | 2020 | 256 | 0.420 |
Why?
|
ras Proteins | 4 | 2022 | 1049 | 0.400 |
Why?
|
Mutation | 11 | 2024 | 29915 | 0.390 |
Why?
|
DNA Copy Number Variations | 2 | 2020 | 2012 | 0.390 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2024 | 8506 | 0.370 |
Why?
|
Astrocytoma | 3 | 2020 | 775 | 0.350 |
Why?
|
Molecular Targeted Therapy | 2 | 2020 | 2796 | 0.330 |
Why?
|
Stem Cells | 1 | 2019 | 3521 | 0.260 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2024 | 2504 | 0.240 |
Why?
|
Brain Stem Neoplasms | 3 | 2017 | 190 | 0.240 |
Why?
|
Neurofibromin 1 | 2 | 2022 | 190 | 0.200 |
Why?
|
DNA Probes | 2 | 2019 | 543 | 0.190 |
Why?
|
Ganglioglioma | 1 | 2020 | 36 | 0.180 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2020 | 42 | 0.170 |
Why?
|
Epigenomics | 3 | 2020 | 936 | 0.170 |
Why?
|
Aminoimidazole Carboxamide | 1 | 2020 | 85 | 0.170 |
Why?
|
Ribonucleotides | 1 | 2020 | 114 | 0.170 |
Why?
|
Child | 15 | 2024 | 79813 | 0.170 |
Why?
|
Chromosomal Instability | 1 | 2019 | 178 | 0.160 |
Why?
|
Oligodendroglioma | 1 | 2019 | 279 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 52 | 0.140 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2018 | 132 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 640 | 0.140 |
Why?
|
RNA Splicing | 1 | 2022 | 913 | 0.140 |
Why?
|
Pathology, Molecular | 1 | 2020 | 328 | 0.140 |
Why?
|
Lysine | 2 | 2020 | 998 | 0.140 |
Why?
|
Child, Preschool | 8 | 2024 | 42058 | 0.140 |
Why?
|
Oncogenes | 1 | 2022 | 1221 | 0.130 |
Why?
|
Comparative Genomic Hybridization | 1 | 2017 | 473 | 0.130 |
Why?
|
Gene Fusion | 1 | 2018 | 354 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2020 | 989 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2020 | 1245 | 0.120 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2020 | 611 | 0.120 |
Why?
|
Methionine | 1 | 2017 | 569 | 0.120 |
Why?
|
DNA, Mitochondrial | 1 | 2020 | 856 | 0.120 |
Why?
|
World Health Organization | 1 | 2020 | 1312 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 698 | 0.110 |
Why?
|
Gene Expression Profiling | 5 | 2024 | 9405 | 0.110 |
Why?
|
Activin Receptors, Type I | 1 | 2014 | 136 | 0.110 |
Why?
|
Infant | 6 | 2024 | 36054 | 0.100 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2019 | 1613 | 0.100 |
Why?
|
Embryonic Stem Cells | 1 | 2019 | 1262 | 0.100 |
Why?
|
Neural Stem Cells | 1 | 2019 | 882 | 0.100 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3840 | 0.090 |
Why?
|
Up-Regulation | 1 | 2020 | 4114 | 0.090 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2017 | 929 | 0.090 |
Why?
|
Polymerase Chain Reaction | 1 | 2020 | 6068 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2020 | 2912 | 0.090 |
Why?
|
Epigenesis, Genetic | 2 | 2020 | 3754 | 0.090 |
Why?
|
Immunohistochemistry | 2 | 2024 | 11070 | 0.090 |
Why?
|
Gene Deletion | 1 | 2017 | 2666 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6493 | 0.080 |
Why?
|
Adolescent | 8 | 2024 | 87888 | 0.080 |
Why?
|
Energy Metabolism | 1 | 2020 | 2868 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 2 | 2019 | 4485 | 0.080 |
Why?
|
Biopsy | 2 | 2017 | 6768 | 0.080 |
Why?
|
Humans | 20 | 2024 | 758381 | 0.070 |
Why?
|
DNA Methylation | 2 | 2019 | 4373 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3615 | 0.070 |
Why?
|
Cohort Studies | 3 | 2020 | 41252 | 0.070 |
Why?
|
Trans-Activators | 1 | 2017 | 2860 | 0.070 |
Why?
|
Sarcoma | 1 | 2018 | 1785 | 0.070 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2019 | 1842 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12096 | 0.070 |
Why?
|
Male | 11 | 2024 | 358742 | 0.060 |
Why?
|
Pediatrics | 2 | 2018 | 3587 | 0.060 |
Why?
|
Prognosis | 4 | 2024 | 29558 | 0.060 |
Why?
|
Proportional Hazards Models | 2 | 2016 | 12440 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5629 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2020 | 7843 | 0.050 |
Why?
|
Infant, Newborn | 2 | 2020 | 26182 | 0.050 |
Why?
|
Female | 10 | 2024 | 390316 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2017 | 11152 | 0.050 |
Why?
|
Spliceosomes | 1 | 2022 | 129 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 7985 | 0.050 |
Why?
|
Genome, Human | 1 | 2014 | 4415 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 11894 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2020 | 15773 | 0.040 |
Why?
|
Genes, Neoplasm | 1 | 2022 | 370 | 0.040 |
Why?
|
Receptor, trkA | 1 | 2019 | 159 | 0.040 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2024 | 1086 | 0.040 |
Why?
|
Methylation | 1 | 2020 | 1080 | 0.040 |
Why?
|
Health Resources | 1 | 2024 | 931 | 0.040 |
Why?
|
Diencephalon | 1 | 2017 | 54 | 0.040 |
Why?
|
Paraffin Embedding | 1 | 2018 | 302 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2022 | 1694 | 0.040 |
Why?
|
Animals | 5 | 2022 | 167777 | 0.030 |
Why?
|
Formaldehyde | 1 | 2018 | 358 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2022 | 1090 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2024 | 2001 | 0.030 |
Why?
|
Exons | 1 | 2022 | 2387 | 0.030 |
Why?
|
Glycolysis | 1 | 2020 | 826 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2019 | 567 | 0.030 |
Why?
|
Gene Dosage | 1 | 2020 | 1218 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2017 | 36285 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39060 | 0.030 |
Why?
|
Inhibitor of Differentiation Protein 1 | 1 | 2014 | 47 | 0.030 |
Why?
|
Inhibitor of Differentiation Protein 2 | 1 | 2014 | 30 | 0.030 |
Why?
|
Smad Proteins | 1 | 2014 | 156 | 0.030 |
Why?
|
Binding Sites | 1 | 2022 | 6036 | 0.030 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3574 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2018 | 4567 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2022 | 2980 | 0.020 |
Why?
|
Base Sequence | 1 | 2022 | 12436 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2015 | 1791 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2019 | 2416 | 0.020 |
Why?
|
Canada | 1 | 2015 | 2111 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2938 | 0.020 |
Why?
|
Immunotherapy | 1 | 2024 | 4641 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3527 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2024 | 10171 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10112 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5861 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14354 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2022 | 16886 | 0.020 |
Why?
|
Neurosurgical Procedures | 1 | 2015 | 2055 | 0.010 |
Why?
|
Mice | 2 | 2022 | 81107 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2018 | 12760 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4711 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8297 | 0.010 |
Why?
|
Zebrafish | 1 | 2014 | 2993 | 0.010 |
Why?
|
Transcription Factors | 1 | 2022 | 12096 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18125 | 0.010 |
Why?
|
Young Adult | 2 | 2019 | 58808 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15785 | 0.010 |
Why?
|
Adult | 2 | 2022 | 219916 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2015 | 64379 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2015 | 80170 | 0.000 |
Why?
|
Concepts
(138)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_